Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Transplantation and Cellular Therapy|April 2, 2021
Association of Factors Influencing Selection of Upfront Hematopoietic Cell Transplantation versus Nontransplantation Therapies in MyelofibrosisElliot Smith, Jingyue Huang, Auro Viswabandya, et al.
Haematologica|February 2, 2023
Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-upKyoung Ha Kim, TaeHyung Kim, Igor Novitzky-Basso, et al.
Ejhaem|September 2, 2022
The 17-gene stemness score associates with relapse risk and long-term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemiaDennis D H Kim, Igor Novitzky Basso, Taehyung Simon Kim, et al.
Cancer|January 25, 2017
Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysisFotios V Michelis, Vikas Gupta, Mei-Jie Zhang, et al.
Bone Marrow Transplantation|March 26, 2021
Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemiaGeorgina Daher-Reyes, TaeHyung Kim, Igor Novitzky-Basso, et al.
Eclinicalmedicine|January 22, 2026
HCT Frailty Scale (HCT-FS) for assessing frailty in adult candidates for allogeneic haematopoietic cell transplantation: an international prospective, observational cohort studyMaría Queralt Salas, Tommy Alfaro Moya, Ivan Pasic, et al.
Blood Advances|September 22, 2021
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AMLKamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, et al.
Bone Marrow Transplantation|September 29, 2021
An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysisAntonio M Jimenez Jimenez, Marcos De Lima, Krishna V Komanduri, et al.
Blood Advances|October 4, 2023
Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysisHemant S Murthy, Mei-Jie Zhang, Karen Chen, et al.
Blood Advances|September 21, 2021
Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemiaMatthew J Wieduwilt, Leland Metheny, Mei-Jie Zhang, et al.
Pageof 13